AzTrials
AzTrials

ShockAFRICANCT02794909

AFrican Resuscitation Ultrasound In Critically-ill Adults

A study testing Cardiopulmonary ultrasound exam in people with Shock and Dyspnea, run by Rockefeller Oteng at 1 site in Ghana.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study is a prospective cohort study in which a select group of emergency physicians at Komfo Anokye Teaching Hospital (KATH) in Ghana will be trained in cardiopulmonary ultrasound (CPUS). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shock, Dyspnea
What is being tested?
Cardiopulmonary ultrasound exam
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteGhana
Study dates
Jul 2016to Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Presence of at least one of the following signs or symptoms of hypoperfusion or hypoxia:
  • Unresponsiveness or altered mental status with a GCS <13
  • Diaphoresis
  • Capillary refill >3 seconds
  • Systolic blood pressure <100 at any point between arrival to the ED and IV fluid administration
  • Tachycardia >100 bpm
  • Tachypnea >20/min
  • Pulse oximetry of <92% at any point between arrival to the ED and administration of supplemental oxygen

Who cannot join

  • Chronic low blood pressure, as evidenced by patient report or documentation
  • ACS, determined by ST elevation on EKG (troponin levels not easily available at study site)
  • Significant resuscitative measures prior to enrollment, including defibrillation, ALS medications, or mechanical ventilation
  • Determination of etiology of shock prior to enrollment, such as obvious signs of major trauma or obvious GI bleeding
  • Onset of signs or symptoms of shock after initial evaluation by a physician

Trial locations and contacts

1 site in 1 country.

Ghana1 site
  • Komfo Anokye Teaching Hospital

    Kumasi, 00233

Other trials in Ghana

About this study

Official title: Pilot Study- Ultrasound-guided Resuscitation of Patients Presenting With Shock or Dyspnea to the Emergency Department in a Resource-limited Setting

The proposed study is a prospective cohort study in which a select group of emergency physicians at Komfo Anokye Teaching Hospital (KATH) in Ghana will be trained in cardiopulmonary ultrasound (CPUS). Following the training, patients who present to the ED with undifferentiated shock and/or dyspnea will either receive usual and customary care supplemented with cardiopulmonary ultrasonography-guided diagnosis and treatment during their initial resuscitation, or usual and customary care alone depending on whether the treating physician has received CPUS training. The main outcomes is the impact of CPUS on correct diagnosis. Information regarding initial treatment strategies, diagnoses and 24-hour mortality will be collected via manual review of paper charts and medical records.

Read the detailed description

Methods:

The training protocol and pilot study have been developed through a collaborative effort involving emergency medicine physicians at University of Michigan (UM) and KATH. Select resident physicians (approximately 1/3 of the emergency medicine resident physicians) at KATH will participate in a one-week, hands-on ultrasound course concentrating on solidifying their preexisting skills in ultrasound, with a focus on the RUSH and BLUE protocols for assessment of critically ill patients. Resident physicians will be trained, as attending physicians are not routinely present during the majority of patient evaluations.

The RUSH (Rapid Ultrasound in SHock) protocol was first described in publication in 2010 and has since become widely used throughout the country to aid in identifying the cause of shock for a patient. It is a three-step ultrasound scanning protocol, first evaluating "the pump" or heart, second "the tank" or intravascular volume status, and third "the pipes" or large arteries and veins. Ultrasound findings from the exam are then compared with those typically seen in hypovolemic shock, cardiogenic shock, obstructive shock and distributive shock (1). The BLUE (Bedside Lung Ultrasound in Emergency) protocol was initially published in 2008 as a quick tool to determine diagnosis in acute respiratory failure. Based on ultrasound findings, this scanning protocol provides specific profiles for six main causes of acute respiratory distress, pulmonary edema, pulmonary embolism, pneumonia, chronic obstructive pulmonary disease, asthma, and pneumothorax (2).

As most of the emergency physicians at KATH have previously expressed interest in receiving this training, we will offer training to all physicians in three different cohorts, 1/3 initially, 1/3 part way through the study, and 1/3 at the end. The physicians in the initial training group will be chosen based off their availability and work schedule. The participants will take a test prior to beginning the training and also at the end. They will also be required to pass an OSCE (Objective Structured Clinical Exam) at the end of the week. One week will be allocated for ultrasound training, to allow the physicians to participate and practice their new skills. These select residents will make up the cohort of CPUS-trained physicians.

The pilot study will be conducted over a four-month period in the emergency department at KATH. All patients presenting to the ED will be screened for study inclusion criteria as defined below by a triage nurse, and informed consent will be obtained by research assistants in all patients deemed competent.

All patients will immediately receive usual and customary care, to include physical examination, IV access, continuous cardiac monitoring, and supplemental oxygen. Following the initial assessment, the treating physician will be asked to choose the most likely diagnosis from a provided checklist. All checklists were designed specifically for research purposes in this study and the information documented on the checklists will be used in clinical decision-making. The information contained in the checklists is based on the well-validated RUSH and BLUE protocols and will be used strictly in the context of these protocols only. The physicians filling out the checklists will be part of the study team at KATH. When a patient meets inclusion criteria and their treating physician has received CPUS-training, the patient will receive a CPUS exam in addition to standard care. In addition to the CPUS exam, any other ultrasound exams deemed necessary for clinical care will occur as they normally do as part of regular standard of care. Ultrasound will not be withheld for any patient as part of their clinical care. There will be no aspects of the study conducted prior to enrollment that will impact care or study design.

Patients in the CPUS group will receive imaging in concordance with the standardized RUSH and BLUE protocols and findings will be documented on a second checklist. Emergency physicians trained in CPUS will perform the ultrasound exams, after which they will again choose the most likely diagnosis from the same initial checklist. The pre-ultrasound and post-ultrasound diagnoses will be recorded for comparison. Diagnostic accuracy will be assessed based on post-hoc review of hospital records. Ultrasound competency will be assessed intermittently by means of direct supervision during site visits to ensure that there is no skill degradation and to ensure safety of study participants.

Data Analysis:

Power analysis was performed for the primary outcome of diagnostic accuracy. Assuming a baseline of 60% correct diagnosis we calculated that 158 subjects are required to detect an absolute 30% increase in correct diagnosis. A minimum of 180 patients will be enrolled to account for loss to follow-up. Additionally, the information gathered during the pilot study will be used to help guide planning for a long-term follow-up study in the future. During the initial ultrasound training, competency will be assessed using pre and post-tests, in addition to OSCE (Objective Structured Clinical Exam). General Linear Model (GLM) framework, with pretest scores as the covariate, will be used to analyze the pre and post-test data. All data from the pilot study will be collected on I-pads or paper copies and transferred into a CSV-formatted file by a research assistant. Data will be examined using SPSS statistical analysis software using linear and (multiple) logistic regression analysis. A p-value of <0.05 will be interpreted as statistically significant.

Ethical Considerations:

Ethics approval will be sought from the Committee for Human Research, Publication and Ethics (CHRPE) of the School of Medical Sciences, Kwame Nkrumah University of science and Technology (S.M.S.-K.N.U.S.T.) and the Institutional Review Board (IRB) of the University of Michigan.

All patients considering taking part in this study will be provided with a consent form describing the interventions and given sufficient time to decide whether or not to participate. When informed consent cannot be obtained from the patient due to incapacitation or impaired decision-making, consent will be obtained from the next of kin or from legally authorized representative. Legal guardians or the head of household can serve as a proxy or legally authorized representative. According to local customs, in the case where there are no parents then the "head of the family" is given proxy. This person may not have court documentation but is presented by the family and accepted as the one to make decisions. Only adults, those over the age of 18, will be included in this study. The subject population consists of the community surrounding KATH which sees a range of patients, from children to adults. Only adults meeting the inclusion criteria will be included in this study.

Confidentiality will be maintained by de-identifying patient information as early as possible during the study and storing personal information and data on secure servers in the United States which will likely be very effective in protecting patient information. In reports, data and discussion are confidential.

Conditions
Shock, Dyspnea
Being tested
Cardiopulmonary ultrasound exam
Keywords
Point-of-care ultrasound, ED, Low and middle-income country, Echocardiography, Lung ultrasound, Resuscitation
Medical subject headings
Shock, Dyspnea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cardiopulmonary ultrasound examDevice

    The cardiopulmonary ultrasound exam consists of a point-of-care ultrasound scan of the heart, lungs, peritoneal cavity, aorta, and femoral veins.

Study groups in NCT02794909
Study groupRoleWhat they receive
CPUS groupExperimentalThe group of patients in the CPUS group will be those who receive a cardiopulmonary ultrasound exam in accordance with a specified CPUS scanning protocol in addition to their routine care. Patients will be in this group if their treating physician has received specific training in the CPUS protocol.
Receives: Device: Cardiopulmonary ultrasound exam
Control groupNo interventionThe group of patients in the control group will be those who do not receive an ultrasound exam in accordance with a specified CPUS scanning protocol in addition to their routine care. Patients will be in this group if their treating physician has not received specific training in the CPUS protocol.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with correct diagnosis after initial evaluation in the emergency department

    Diagnostic accuracy will be assessed by comparing the initial diagnosis, documented on the "second diagnosis checklist" within one hour of first physician contact in the emergency department, and final diagnosis as documented in the patient's chart at the time of discharge or death.

    Measured: Upon discharge from ED or at 24 hours, whichever comes first

Secondary outcomes (2)
  1. The amount of IV fluids given to the patient in the emergency department and whether or not the following therapies were employed: invasive ventilation, non-invasive ventilation, diuretics, bronchodilators, and vasopressors

    Impact on treatment will be assessed by comparing the amount of IV fluids given to the two groups as obtained through chart review. The presence or absence of the following therapies (yes/no) will also be obtained via chart review: invasive ventilation, non-invasive ventilation, diuretics, bronchodilators, and vasopressors.

    Measured: Upon discharge from ED or at 24 hours, whichever comes first

  2. Number of patients alive

    Mortality will be compared between the two groups by documenting the number of patients alive at 24 hours and also at end of the hospital stay (at discharge from hospital).

    Measured: At 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionJan 2017
  4. Study completionJan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02794909
Sponsor's protocol ID
HUM00110695
Acronym
AFRICA
Status last verified
Feb 2017
First submitted
23 May 2016
Last updated
23 Feb 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Perera P, Mailhot T, Riley D, Mandavia D. The RUSH exam: Rapid Ultrasound in SHock in the evaluation of the critically lll. Emerg Med Clin North Am. 2010 Feb;28(1):29-56, vii. doi: 10.1016/j.emc.2009.09.010.

    PubMed 19945597
  • Lichtenstein DA, Meziere GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008 Jul;134(1):117-25. doi: 10.1378/chest.07-2800. Epub 2008 Apr 10.

    PubMed 18403664

Questions about this trial

What is this clinical trial studying?

A study testing Cardiopulmonary ultrasound exam in people with Shock and Dyspnea, run by Rockefeller Oteng at 1 site in Ghana.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ghana. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with correct diagnosis after initial evaluation in the emergency department (time frame: Upon discharge from ED or at 24 hours, whichever comes first). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02794909, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in